heart failure therapeutics (Stanford University School of Medicine)

N/A

Report date: 2025/03/20 15:36:31
NME

Base Information

Drug Nameheart failure therapeutics (Stanford University School of Medicine)
Drug Alias Namesk-09111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 2 agonists
TargetsOrexin receptor type 2
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStanford University School of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesStanford University School of Medicine
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A